Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 2,409 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Invasive Procedure Clear all

Conditions: Candidemia
Interventions: Not listed
Lead sponsor: T2 Biosystems; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Birmingham, Alabama • Pittsburgh, Pennsylvania • Providence, Rhode Island

Conditions: Craniosynostosis
Interventions: MR scan; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Up to 18 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Invasive Fungal Infections
Interventions: Micafungin, Placebo; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 16 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003
U.S. locations: 41
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 32 more

Conditions: Prostate Cancer
Interventions: MR-Guided Transurethral US Ablation of Prostate Tissue; Device
Lead sponsor: Profound Medical Inc.; Other
Eligibility: 65 Years to 75 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Pain, Anxiety
Interventions: Self-hypnotic relaxation; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Candidiasis
Interventions: Anidulafungin, Fluconazole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 16 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: King of Prussia, Pennsylvania

Conditions: Heart Failure
Interventions: RHC with VO2 consumption; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Restless Legs Syndrome
Interventions: Noninvasive Peripheral Nerve Stimulation (NPNS); Device
Lead sponsor: Noctrix Health, Inc.; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Downey, California • Dublin, Ohio

Conditions: Intracranial Hypertension, Abnormality of Intracranial Pressure
Interventions: Non-invasive ICP measurement; Diagnostic Test
Lead sponsor: Boston Neurosciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 4
States / cities: Phoenix, Arizona • Atlanta, Georgia • Philadelphia, Pennsylvania + 1 more

Conditions: LIPOLYSIS
Interventions: reborn treatment; Device
Lead sponsor: Lightfective Ltd; Industry
Eligibility: 22 Years and older
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Tennessee City, Tennessee

Conditions: Complications of Pregnancy, Childbirth and the Puerperium
Interventions: Masimo Rainbow Sensor; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Urinary Bladder Neoplasms
Interventions: TAR-200, Cetrelimab; Drug · Biological
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 41
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 32 more

Conditions: Ductal Carcinoma in Situ
Interventions: Cryoablation; Procedure
Lead sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: Patients With Spinal Stenosis Indicated for MIS TLIF
Interventions: Erector spinae plane (ESP) block; Procedure
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Aging, Mild Cognitive Impairment
Interventions: real tACS, sham tACS; Other
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years to 95 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Interventions: Sacituzumab Govitecan (SG), Nivolumab; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Postoperative Pain, Medication Side Effects, Narcotic Requirement
Interventions: IV acetaminophen; Drug
Lead sponsor: Gundersen Lutheran Medical Foundation; Other
Eligibility: 18 Years to 90 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Complications; Cesarean Section, Anesthesia; Adverse Effect, Spinal and Epidural
Interventions: experimental, Control; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Carvedilol CR, Atenolol; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Collagen Fibril Alteration
Interventions: Tretinoin cream 0.1%; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 45 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Irvine, California

Conditions: Candidiasis, Invasive, Candidemia
Interventions: SCY-078, Fluconazole, Echinocandin; Drug
Lead sponsor: Scynexis, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 26
States / cities: Birmingham, Alabama • Tucson, Arizona • Sacramento, California + 19 more

Conditions: Muscle Invasive Bladder Urothelial Carcinoma
Interventions: Daily Adaptive External Beam Radiation Therapy; Radiation
Lead sponsor: Varian, a Siemens Healthineers Company; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity
Interventions: Standard Laparoscopic Approach, Percutaneous Approach; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Superficial Bladder Cancer
Interventions: BC-819/PEI; Biological
Lead sponsor: Anchiano Therapeutics Israel Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Serial Therapeutic and Antifungal Monitoring Protocol

MRI for Non-invasive Evaluation of Brain Stress

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer

Nonpharmacologic Analgesia for Invasive Procedures

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Mechanisms in Heart Failure With Normal EF

Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment

Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ

ESP Block in MIS Lumbar Spine Surgery

Modulating Cortical Dynamics of Dual-task Standing in MCI

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Pain Control After Minimally Invasive Coronary Artery Bypass Grafting

Non-invasive Cardiac Output Monitoring in Obstetric Patients

Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer

Psychology of Minimally Invasive Surgical Scars

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer